Seletracetam is an analog of the antiepileptic agent Levetiracetam. Seletracetam is a small molecule SV2A modulator for the research of epilepsy.

Seletracetam inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro. Seletracetam decreases synaptic responses in time-, frequency- and concentration-dependent manner. Seletracetam decreases seizure activity in a number of epilepsy models and binds to the synaptic vesicle protein SV2A. Seletracetam modifies rates of presynaptic release [2].

357336-74-4

C10H14F2N2O2

232.23

Ucb 44212;Seletracetam

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years